Regulation of lysosome biogenesis and functions in osteoclasts

Cell Cycle

Volumn 12, Issue 17, 2013, Pages 2744-2752

  Lacombe, Julie ^a   Karsenty, Gérard ^b   Ferron, Mathieu ^a,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b Columbia University ^*  (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bone resorption; Lysosomal biogenesis; Lysosome; Osteoclast; PKC ; RANKL; TFEB

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AUTOPHAGY PROTEIN 5; CATHEPSIN K; COLLAGENASE 3; GELATINASE B; GUANOSINE TRIPHOSPHATASE; MANNOSE 6 PHOSPHATE; MEMBRANE PROTEIN; PHOSPHOTRANSFERASE; PROTEIN KINASE C DELTA; RAB PROTEIN; SORTING NEXIN; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR;

BIOGENESIS; CELL FUNCTION; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; LYSOSOME; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW;

LACUNA;

BONE RESORPTION; LYSOSOMAL BIOGENESIS; LYSOSOME; OSTEOCLAST; PKCΒ; RANKL; TFEB;

ACIDS; BONE AND BONES; EXTRACELLULAR MATRIX; HUMANS; LYSOSOMES; OSTEOCLASTS; PROTEINS;

EID: 84883562970     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25825     Document Type: Review

References (97)

1. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289:1501-4; PMID:10968779; http://dx.doi.org/10.1126/science.289.5484.1501
2. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289:1504-8; PMID:10968780; http://dx.doi.org/10.1126/science.289.5484.1504
3. Tolar J, Teitelbaum SL, Orchard PJ. Osteopetrosis. N Engl J Med 2004; 351:2839-49; PMID:15625335; http://dx.doi.org/10.1056/NEJMra040952
4. Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003; 4:638-49; PMID:12897775; http://dx.doi.org/10. 1038/nrg1122
5. Segovia-Silvestre T, Neutzsky-Wulff AV, Sorensen MG, Christiansen C, Bollerslev J, Karsdal MA, Henriksen K. Advances in osteoclast biology resulting from the study of osteopetrotic mutations. Hum Genet 2009; 124:561-77; PMID:18987890; http://dx.doi.org/10.1007/s00439-008-0583-8
6. Karsenty G, Kronenberg HM, Settembre C. Genetic control of bone formation. Annu Rev Cell Dev Biol 2009; 25:629-48; PMID:19575648; http://dx.doi.org/10.1146/annurev.cellbio.042308.113308
7. Schinke T, Schilling AF, Baranowsky A, Seitz S, Marshall RP, Linn T, Blaeker M, Huebner AK, Schulz A, Simon R, et al. Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med 2009; 15:674-81; PMID:19448635; http://dx.doi.org/10.1038/nm.1963
8. Mansour A, Wakkach A, Blin-Wakkach C. Role of osteoclasts in the hematopoietic stem cell niche formation. Cell Cycle 2012; 11:2045-6; PMID:22580466; http://dx.doi.org/10.4161/cc.20534
9. Mansour A, Abou-Ezzi G, Sitnicka E, Jacobsen SE, Wakkach A, Blin-Wakkach C. Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow. J Exp Med 2012; 209:537-49; PMID:22351931; http://dx.doi.org/10. 1084/jem.20110994
10. Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 2011; 117:1540-9; PMID:21131587; http://dx.doi.org/10.1182/blood-2010-05-282855
11. Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006; 12:657-64; PMID:16715089; http://dx.doi.org/10.1038/nm1417
12. Miyamoto K, Yoshida S, Kawasumi M, Hashimoto K, Kimura T, Sato Y, Kobayashi T, Miyauchi Y, Hoshi H, Iwasaki R, et al. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med 2011; 208:2175-81; PMID:22006978; http://dx.doi.org/10.1084/jem.20101890
13. Takamatsu Y, Simmons PJ, Moore RJ, Morris HA, To LB, Levesque JP. Osteoclast-mediated bone resorption is stimulated during short-term administration of granulocyte colony-stimulating factor but is not responsible for hematopoietic progenitor cell mobilization. Blood 1998; 92:3465-73; PMID:9787189
14. Ferron M, Wei J, Yoshizawa T, Del Fattore A, DePinho RA, Teti A, Ducy P, Karsenty G. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010; 142:296-308; PMID:20655470; http://dx.doi.org/10. 1016/j.cell.2010.06.003
15. Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 2013; 123:2421-33; PMID:23728177; http://dx.doi.org/10.1172/JCI65952.
16. Lotinun S, Kiviranta R, Matsubara T, Alzate JA, Neff L, Luth A, Koskivirta I, Kleuser B, Vacher J, Vuorio E, et al. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. J Clin Invest 2013; 123:666-81; PMID:23321671
17. Teitelbaum SL. The osteoclast and its unique cytoskeleton. Ann N Y Acad Sci 2011; 1240:14-7; PMID:22172034; http://dx.doi.org/10.1111/j.1749-6632.2011. 06283.x
18. Coxon FP, Taylor A. Vesicular trafficking in osteoclasts. Semin Cell Dev Biol 2008; 19:424-33; PMID:18768162; http://dx.doi.org/10.1016/j.semcdb.2008.08. 004
19. Zhao H, Patrick Ross F. Mechanisms of osteoclastic secretion. Ann N Y Acad Sci 2007; 1116:238-44; PMID:18083931; http://dx.doi.org/10.1196/annals. 1402.058
20. Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet 2000; 25:343-6; PMID:10888887; http://dx.doi.org/10.1038/77131
21. Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 2000; 26:207-13; PMID:10709991; http://dx.doi.org/10.1016/S8756-3282(99)00278-1
22. Voronov I, Ochotny N, Jaumouille V, Owen C, Manolson MF, Aubin JE. The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis. J Bone Miner Res 2013; 28:108-18; PMID:22865292; http://dx.doi.org/10.1002/jbmr.1727
23. Wu H, Xu G, Li YP. Atp6v0d2 is an essential component of the osteoclast-specific proton pump that mediates extracellular acidification in bone resorption. J Bone Miner Res 2009; 24:871-85; PMID:19113919; http://dx.doi.org/10.1359/jbmr.081239
24. Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2006; 12:1403-9; PMID:17128270; http://dx.doi.org/10.1038/nm1514
25. Feng S, Deng L, Chen W, Shao J, Xu G, Li YP. Atp6v1c1 is an essential component of the osteoclast proton pump and in F-actin ring formation in osteoclasts. Biochem J 2009; 417:195-203; PMID:18657050; http://dx.doi.org/10. 1042/BJ20081073
26. Jansen EJ, Martens GJ. Novel insights into V-ATPase functioning: distinct roles for its accessory subunits ATP6AP1/Ac45 and ATP6AP2/(pro) renin receptor. Curr Protein Pept Sci 2012; 13:124-33; PMID:22044156; http://dx.doi.org/10. 2174/138920312800493160
27. Yang DQ, Feng S, Chen W, Zhao H, Paulson C, Li YP. V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption. J Bone Miner Res 2012; 27:1695-707; PMID:22467241; http://dx.doi.org/10.1002/jbmr.1623
28. Cleiren E, Benichou O, Van Hul E, Gram J, Bollerslev J, Singer FR, Beaverson K, Aledo A, Whyte MP, Yoneyama T, et al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene. Hum Mol Genet 2001; 10:2861-7; PMID:11741829; http://dx.doi.org/10.1093/hmg/10.25.2861
29. Kornak U, Kasper D, Bosl MR, Kaiser E, Schweizer M, Schulz A, Friedrich W, Delling G, Jentsch TJ. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104:205-15; PMID:11207362; http://dx.doi.org/10.1016/S0092-8674(01)00206-9
30. Waguespack SG, Koller DL, White KE, Fishburn T, Carn G, Buckwalter KA, Johnson M, Kocisko M, Evans WE, Foroud T, et al. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II. J Bone Miner Res 2003; 18:1513-8; PMID:12929941; http://dx.doi.org/10.1359/jbmr.2003.18.8.1513
31. Weinert S, Jabs S, Supanchart C, Schweizer M, Gimber N, Richter M, Rademann J, Stauber T, Kornak U, Jentsch TJ. Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl-accumulation. Science 2010; 328:1401-3; PMID:20430974; http://dx.doi.org/10.1126/science.1188072
32. Graves AR, Curran PK, Smith CL, Mindell JA. The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature 2008; 453:788-92; PMID:18449189; http://dx.doi.org/10.1038/nature06907
33. Okamoto F, Kajiya H, Toh K, Uchida S, Yoshikawa M, Sasaki S, Kido MA, Tanaka T, Okabe K. Intracellular ClC-3 chloride channels promote bone resorption in vitro through organelle acidification in mouse osteoclasts. Am J Physiol Cell Physiol 2008; 294:C693-701; PMID:18234851; http://dx.doi.org/10.1152/ ajpcell.00251.2007
34. Chalhoub N, Benachenhou N, Rajapurohitam V, Pata M, Ferron M, Frattini A, Villa A, Vacher J. Greylethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat Med 2003; 9:399-406; PMID:12627228; http://dx.doi.org/10.1038/nm842
35. Lange PF, Wartosch L, Jentsch TJ, Fuhrmann JC. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 2006; 440:220-3; PMID:16525474; http://dx.doi.org/10.1038/nature04535
36. Maranda B, Chabot G, Decarie JC, Pata M, Azeddine B, Moreau A, Vacher J. Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis. J Bone Miner Res 2008; 23:296-300; PMID:17922613; http://dx.doi.org/10.1359/jbmr. 071015
37. Pangrazio A, Poliani PL, Megarbane A, Lefranc G, Lanino E, Di Rocco M, Rucci F, Lucchini F, Ravanini M, Facchetti F, et al. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J Bone Miner Res 2006; 21:1098-105; PMID:16813530; http://dx.doi.org/10.1359/jbmr.060403
38. Pata M, Heraud C, Vacher J. OSTM1 bone defect reveals an intercellular hematopoietic crosstalk. J Biol Chem 2008; 283:30522-30; PMID:18790735; http://dx.doi.org/10.1074/jbc.M805242200
39. Kasper D, Planells-Cases R, Fuhrmann JC, Scheel O, Zeitz O, Ruether K, Schmitt A, Poet M, Steinfeld R, Schweizer M, et al. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J 2005; 24:1079-91; PMID:15706348; http://dx.doi.org/10.1038/sj.emboj.7600576
40. Campeau PM, Lu JT, Sule G, Jiang MM, Bae Y, Madan S, Hogler W, Shaw NJ, Mumm S, Gibbs RA, et al. Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis. Hum Mol Genet 2012; 21:4904-9; PMID:22875837; http://dx.doi.org/10.1093/hmg/dds326
41. Hsu CL, Lin W, Seshasayee D, Chen YH, Ding X, Lin Z, Suto E, Huang Z, Lee WP, Park H, et al. Equilibrative nucleoside transporter 3 deficiency perturbs lysosome function and macrophage homeostasis. Science 2012; 335:89-92; PMID:22174130; http://dx.doi.org/10.1126/science.1213682
42. Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996; 273:1236-8; PMID:8703060; http://dx.doi.org/10.1126/science.273.5279.1236
43. Li CY, Jepsen KJ, Majeska RJ, Zhang J, Ni R, Gelb BD, Schaffler MB. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res 2006; 21:865-75; PMID:16753017; http://dx.doi.org/10.1359/jbmr.060313
44. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A 1998; 95:13453-8; PMID:9811821; http://dx.doi.org/10.1073/pnas.95.23.13453
45. Henriksen K, Sorensen MG, Nielsen RH, Gram J, Schaller S, Dziegiel MH, Everts V, Bollerslev J, Karsdal MA. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification. J Bone Miner Res 2006; 21:58-66; PMID:16355274; http://dx.doi.org/10.1359/JBMR.050905
46. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004; 131:5883-95; PMID:15539485; http://dx.doi.org/10.1242/dev.01461
47. Lausch E, Keppler R, Hilbert K, Cormier-Daire V, Nikkel S, Nishimura G, Unger S, Spranger J, Superti-Furga A, Zabel B. Mutations in MMP9 and MMP13 determine the mode of inheritance and the clinical spectrum of metaphyseal anadysplasia. Am J Hum Genet 2009; 85:168-78; PMID:19615667; http://dx.doi.org/10.1016/j.ajhg.2009.06.014
48. Ljusberg J, Wang Y, Lang P, Norgard M, Dodds R, Hultenby K, Ek-Rylander B, Andersson G. Proteolytic excision of a repressive loop domain in tartrate-resistant acid phosphatase by cathepsin K in osteoclasts. J Biol Chem 2005; 280:28370-81; PMID:15929988; http://dx.doi.org/10.1074/jbc.M502469200
49. Reinholt FP, Widholm SM, Ek-Rylander B, Andersson G. Ultrastructural localization of a tartrate-resistant acid ATPase in bone. J Bone Miner Res 1990; 5:1055-61; PMID:2150467; http://dx.doi.org/10.1002/jbmr.5650051009
50. Hayman AR, Jones SJ, Boyde A, Foster D, Colledge WH, Carlton MB, Evans MJ, Cox TM. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 1996; 122:3151-62; PMID:8898228
51. Suter A, Everts V, Boyde A, Jones SJ, Lullmann-Rauch R, Hartmann D, Hayman AR, Cox TM, Evans MJ, Meister T, et al. Overlapping functions of lysosomal acid phosphatase (LAP) and tartrateresistant acid phosphatase (Acp5) revealed by doubly deficient mice. Development 2001; 128:4899-910; PMID:11731469
52. Briggs TA, Rice GI, Daly S, Urquhart J, Gornall H, Bader-Meunier B, Baskar K, Baskar S, Baudouin V, Beresford MW, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 2011; 43:127-31; PMID:21217755; http://dx.doi.org/10.1038/ng.748
53. Lausch E, Janecke A, Bros M, Trojandt S, Alanay Y, De Laet C, Hubner CA, Meinecke P, Nishimura G, Matsuo M, et al. Genetic deficiency of tartrateresistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet 2011; 43:132-7; PMID:21217752; http://dx.doi.org/10.1038/ng.749
54. Ek-Rylander B, Andersson G. Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase. Exp Cell Res 2010; 316:443-51; PMID:19854170; http://dx.doi.org/10.1016/j.yexcr. 2009.10.019
55. Sun P, Sleat DE, Lecocq M, Hayman AR, Jadot M, Lobel P. Acid phosphatase 5 is responsible for removing the mannose 6-phosphate recognition marker from lysosomal proteins. Proc Natl Acad Sci U S A 2008; 105:16590-5; PMID:18940929; http://dx.doi.org/10.1073/pnas.0807472105
56. Makrypidi G, Damme M, Muller-Loennies S, Trusch M, Schmidt B, Schluter H, Heeren J, Lubke T, Saftig P, Braulke T. Mannose 6 dephosphorylation of lysosomal proteins mediated by acid phosphatases Acp2 and Acp5. Mol Cell Biol 2012; 32:774-82; PMID:22158965; http://dx.doi.org/10.1128/MCB.06195-11
57. Zhao H, Laitala-Leinonen T, Parikka V, Vaananen HK. Downregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorption. J Biol Chem 2001; 276:39295-302; PMID:11514537; http://dx.doi.org/10.1074/jbc. M010999200
58. Sun Y, Buki KG, Ettala O, Vaaraniemi JP, Vaananen HK. Possible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclasts. J Biol Chem 2005; 280:32356-61; PMID:16040606; http://dx.doi.org/10.1074/jbc.M414213200
59. Pavlos NJ, Xu J, Riedel D, Yeoh JS, Teitelbaum SL, Papadimitriou JM, Jahn R, Ross FP, Zheng MH. Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption. Mol Cell Biol 2005; 25:5253-69; PMID:15923639; http://dx.doi.org/10.1128/MCB.25.12.5253-5269.2005
60. Detter JC, Zhang Q, Mules EH, Novak EK, Mishra VS, Li W, McMurtrie EB, Tchernev VT, Wallace MR, Seabra MC, et al. Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proc Natl Acad Sci U S A 2000; 97:4144-9; PMID:10737774; http://dx.doi.org/10. 1073/pnas.080517697
61. Taylor A, Mules EH, Seabra MC, Helfrich MH, Rogers MJ, Coxon FP. Impaired prenylation of Rab GTPases in the gunmetal mouse causes defects in bone cell function. Small GTPases 2011; 2:131-42; PMID:21776414; http://dx.doi.org/10. 4161/sgtp.2.3.16488
62. Zhao H, Ito Y, Chappel J, Andrews NW, Teitelbaum SL, Ross FP. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion. Dev Cell 2008; 14:914-25; PMID:18539119; http://dx.doi.org/10.1016/j.devcel.2008.03.022
63. Tabata K, Matsunaga K, Sakane A, Sasaki T, Noda T, Yoshimori T. Rubicon and PLEKHM1 negatively regulate the endocytic/autophagic pathway via a novel Rab7-binding domain. Mol Biol Cell 2010; 21:4162-72; PMID:20943950; http://dx.doi.org/10.1091/mbc. E10-06-0495
64. Van Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van Hul E, Timmermans JP, Vanhoenacker F, et al. Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans. J Clin Invest 2007; 117:919-30; PMID:17404618; http://dx.doi.org/10.1172/JCI30328
65. Del Fattore A, Fornari R, Van Wesenbeeck L, de Freitas F, Timmermans JP, Peruzzi B, Cappariello A, Rucci N, Spera G, Helfrich MH, et al. A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts. J Bone Miner Res 2008; 23:380-91; PMID:17997709; http://dx.doi.org/10.1359/jbmr.071107
66. DeSelm CJ, Miller BC, Zou W, Beatty WL, van Meel E, Takahata Y, Klumperman J, Tooze SA, Teitelbaum SL, Virgin HW. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell 2011; 21:966-74; PMID:22055344; http://dx.doi.org/10.1016/j.devcel.2011.08.016
67. Pavlos NJ, Cheng TS, Qin A, Ng PY, Feng HT, Ang ES, Carrello A, Sung CH, Jahn R, Zheng MH, et al. Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption. Mol Cell Biol 2011; 31:1551-64; PMID:21262767; http://dx.doi.org/10.1128/MCB.00834-10
68. Ng PY, Cheng TS, Zhao H, Ye S, Sm Ang E, Khor EC, Feng HT, Xu J, Zheng MH, Pavlos NJ. Disruption of the dynein-dynactin complex unveils motor-specific functions in osteoclast formation and bone resorption. J Bone Miner Res 2013; 28:119-34; PMID:22887640; http://dx.doi.org/10.1002/jbmr.1725
69. Ye S, Fowler TW, Pavlos NJ, Ng PY, Liang K, Feng Y, Zheng M, Kurten R, Manolagas SC, Zhao H. LIS1 regulates osteoclast formation and function through its interactions with dynein/dynactin and Plekhm1. PLoS One 2011; 6:e27285; PMID:22073305; http://dx.doi.org/10.1371/journal.pone.0027285
70. Okumura S, Mizoguchi T, Sato N, Yamaki M, Kobayashi Y, Yamauchi H, Ozawa H, Udagawa N, Takahashi N. Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks. Bone 2006; 39:684-93; PMID:16774853; http://dx.doi.org/10.1016/j.bone.2006.04.010
71. Pangrazio A, Fasth A, Sbardellati A, Orchard PJ, Kasow KA, Raza J, Albayrak C, Albayrak D, Vanakker OM, De Moerloose B, et al. SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity. J Bone Miner Res 2013; 28:1041-9; PMID:23280965; http://dx.doi.org/10.1002/jbmr.1849
72. Megarbane A, Pangrazio A, Villa A, Chouery E, Maarawi J, Sabbagh S, Lefranc G, Sobacchi C. Homozygous stop mutation in the SNX10 gene in a consanguineous Iraqi boy with osteopetrosis and corpus callosum hypoplasia. Eur J Med Genet 2013; 56:32-5; PMID:23123320; http://dx.doi.org/10.1016/j.ejmg.2012. 10.010
73. Aker M, Rouvinski A, Hashavia S, Ta-Shma A, Shaag A, Zenvirt S, Israel S, Weintraub M, Taraboulos A, Bar-Shavit Z, et al. An SNX10 mutation causes malignant osteopetrosis of infancy. J Med Genet 2012; 49:221-6; PMID:22499339; http://dx.doi.org/10.1136/jmedgenet-2011-100520
74. Zhu CH, Morse LR, Battaglino RA. SNX10 is required for osteoclast formation and resorption activity. J Cell Biochem 2012; 113:1608-15; PMID:22174188
75. Chen Y, Wu B, Xu L, Li H, Xia J, Yin W, Li Z, Shi D, Li S, Lin S, et al. A SNX10/V-ATPase pathway regulates ciliogenesis in vitro and in vivo. Cell Res 2012; 22:333-45; PMID:21844891; http://dx.doi.org/10.1038/cr.2011.134
76. Cremasco V, Decker CE, Stumpo D, Blackshear PJ, Nakayama KI, Nakayama K, Lupu TS, Graham DB, Novack DV, Faccio R. Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts. J Bone Miner Res 2012; 27:2452-63; PMID:22806935; http://dx.doi.org/10.1002/jbmr.1701
77. van Meel E, Boonen M, Zhao H, Oorschot V, Ross FP, Kornfeld S, Klumperman J. Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis. Traffic 2011; 12:912-24; PMID:21466643; http://dx.doi.org/10.1111/j.1600-0854.2011.01203.x
78. Tondravi MM, McKercher SR, Anderson K, Erdmann JM, Quiroz M, Maki R, Teitelbaum SL. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 1997; 386:81-4; PMID:9052784; http://dx.doi.org/10.1038/386081a0
79. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994; 266:443-8; PMID:7939685; http://dx.doi.org/10.1126/science.7939685
80. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 1997; 3:1285-9; PMID:9359707; http://dx.doi.org/10.1038/nm1197-1285
81. Wan Y, Chong LW, Evans RM. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med 2007; 13:1496-503; PMID:18059282; http://dx.doi.org/10.1038/nm1672
82. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002; 3:889-901; PMID:12479813; http://dx.doi.org/10.1016/S1534-5807(02)00369-6
83. Steingrimsson E, Tessarollo L, Pathak B, Hou L, Arnheiter H, Copeland NG, Jenkins NA. Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc Natl Acad Sci U S A 2002; 99:4477-82; PMID:11930005; http://dx.doi.org/10.1073/pnas.072071099
84. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-76; PMID:9568710; http://dx.doi.org/10.1016/S0092-8674(00)81569-X
85. Burgess TL, Qian Y, Kaufman S, Ring BD, Van G, Capparelli C, Kelley M, Hsu H, Boyle WJ, Dunstan CR, et al. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 1999; 145:527-38; PMID:10225954; http://dx.doi.org/10.1083/jcb.145.3.527
86. Ferron M, Settembre C, Shimazu J, Lacombe J, Kato S, Rawlings DJ, Ballabio A, Karsenty G. A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev 2013; 27:955-69; PMID:23599343; http://dx.doi.org/10.1101/gad.213827.113
87. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, et al. A gene network regulating lysosomal biogenesis and function. Science 2009; 325:473-7; PMID:19556463
88. Fisher DE, Carr CS, Parent LA, Sharp PA. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. Genes Dev 1991; 5(12A):2342-52; PMID:1748288; http://dx.doi.org/10.1101/gad.5. 12a.2342
89. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, et al. TFEB links autophagy to lysosomal biogenesis. Science 2011; 332:1429-33; PMID:21617040; http://dx.doi.org/10.1126/science.1204592
90. Sorensen MG, Karsdal MA, Dziegiel MH, Boutin JA, Nosjean O, Henriksen K. Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption. BMC Musculoskelet Disord 2010; 11:250; PMID:20977756; http://dx.doi.org/10.1186/1471-2474-11-250
91. Williams JP, Thames AM 3rd, McKenna MA, McDonald JM. Differential effects of calmodulin and protein kinase C antagonists on bone resorption and acid transport activity. Calcif Tissue Int 2003; 73:290-6; PMID:14667143; http://dx.doi.org/10.1007/s00223-002-0012-2
92. Lee SW, Kwak HB, Chung WJ, Cheong H, Kim HH, Lee ZH. Participation of protein kinase C beta in osteoclast differentiation and function. Bone 2003; 32:217-27; PMID:12667549; http://dx.doi.org/10.1016/S8756-3282(02)00976-6
93. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 2012; 5:ra42; PMID:22692423; http://dx.doi.org/10.1126/scisignal.2002790
94. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 2012; 31:1095-108; PMID:22343943; http://dx.doi.org/10.1038/emboj.2012.32
95. Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol 2013; 15:647-58; PMID:23604321; http://dx.doi.org/10.1038/ncb2718
96. Pena-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L, et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J 2011; On-line.
97. Chauhan S, Goodwin JG, Chauhan S, Manyam G, Wang J, Kamat AM, Boyd DD. ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell 2013; 50:16-28; PMID:23434374; http://dx.doi.org/10.1016/j.molcel.2013.01.024